Centralized databases enhance drug safety monitoring by enabling real-time data access, improving signal detection, and ensuring regulatory compliance across global pharmacovigilance systems efficiently and accurately.

AI is revolutionizing pharmacovigilance by automating case intake, signal detection, literature review, and reporting—ensuring faster, safer, and more compliant drug safety monitoring.